Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

High Incidence of GalNAc Disialosyl Lactotetraosylceramide in Metastatic Renal Cell Carcinoma

RYO MARUYAMA, SEIICHI SAITO, VLADIMIR BILIM, NOBORU HARA, TOSHIYUKI ITOI, KAZUTOSHI YAMANA, TSUTOMU NISHIYAMA, YOICHI ARAI, KOTA TAKAHASHI and YOSHIHIKO TOMITA
Anticancer Research November 2007, 27 (6C) 4345-4350;
RYO MARUYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEIICHI SAITO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VLADIMIR BILIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBORU HARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIYUKI ITOI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUTOSHI YAMANA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUTOMU NISHIYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOICHI ARAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOTA TAKAHASHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIKO TOMITA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ytomita@med.id.yamagata-u.ac.jp
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 6C 4345-4350
PubMed 
18214042

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 14, 2007
  • Accepted October 4, 2007
  • Published online November 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. RYO MARUYAMA1,
  2. SEIICHI SAITO2,
  3. VLADIMIR BILIM3,
  4. NOBORU HARA1,
  5. TOSHIYUKI ITOI1,
  6. KAZUTOSHI YAMANA1,
  7. TSUTOMU NISHIYAMA1,
  8. YOICHI ARAI2,
  9. KOTA TAKAHASHI1 and
  10. YOSHIHIKO TOMITA3
  1. 1Division of Molecular Oncology, Department of Signal Transduction Research, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510
  2. 2Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8574
  3. 3Department of Urology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan
  1. Correspondence to: Yoshihiko Tomita, Department of Urology, Yamagata University Faculty of Medicine, Iida-nishi 2-2-2, Yamagata 990-9585, Japan. Tel: +81 23 628 5366, Fax: +81 23 628 5370, e-mail: ytomita{at}med.id.yamagata-u.ac.jp

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 27 (6C)
Anticancer Research
Vol. 27, Issue 6C
November-December 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High Incidence of GalNAc Disialosyl Lactotetraosylceramide in Metastatic Renal Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
High Incidence of GalNAc Disialosyl Lactotetraosylceramide in Metastatic Renal Cell Carcinoma
RYO MARUYAMA, SEIICHI SAITO, VLADIMIR BILIM, NOBORU HARA, TOSHIYUKI ITOI, KAZUTOSHI YAMANA, TSUTOMU NISHIYAMA, YOICHI ARAI, KOTA TAKAHASHI, YOSHIHIKO TOMITA
Anticancer Research Nov 2007, 27 (6C) 4345-4350;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
High Incidence of GalNAc Disialosyl Lactotetraosylceramide in Metastatic Renal Cell Carcinoma
RYO MARUYAMA, SEIICHI SAITO, VLADIMIR BILIM, NOBORU HARA, TOSHIYUKI ITOI, KAZUTOSHI YAMANA, TSUTOMU NISHIYAMA, YOICHI ARAI, KOTA TAKAHASHI, YOSHIHIKO TOMITA
Anticancer Research Nov 2007, 27 (6C) 4345-4350;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate Cancer
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire